semaglutide vs tirzepatide weight loss differences Tirzepatide: Loss, Dosing, Timelines & Before and After Results Semaglutide vs. Tirzepatide: Which GLP-1

The most common adverse effects of tirzepatide at weight management doses include gastrointestinal symptoms such as nausea (24-43% of patients), diarrhea (18-31%), vomiting (8-24%), constipation (16-24%), and abdominal pain (10-20%), according to the FDA label

Thyroid Function Testing and Dosing Adjustments Before starting semaglutide, obtain a baseline thyroid panel including TSH and free T4

To assess how GLP-1s may impact adults in the type 1 diabetes population, researchers analyzed data from the TriNetX database of patients with type 1 diabetes using a GLP-1 receptor agonist or other incretin-based medication

Tian JJ, Li YP, Xia Y, Zhang K, Li ZF, Gong WB, et al

As with any therapeutic intervention, consulting with medical professionals for personalized guidance is essential for safe and appropriate use